Sort
11,323 grants matching “glioblastoma”
Genomic &Genetic Characterization of Amplicons in GBMs
$304,380Dana-Farber Cancer Institute · R01 · FY2004 · CA
Genomic &Genetic Characterization of Amplicons in GBMs
$304,380Dana-Farber Cancer Institute · R01 · FY2003 · CA
Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB
$304,373Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R01 · FY2010 · CA
Autophagy in Brain Tumor
$304,364Jin-Ming Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2013 · CA
In vivo detection of involvement of endogenous BM progenitor cells in glioma
$304,261Ali Syed Arbab · Augusta University · R01 · FY2014 · CA
Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB
$304,118Albert Sidney Baldwin · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA
Measuring multiprotein assemblies that drive biological signals
$304,030Adam G. Schrum · Mayo Clinic Rochester · R01 · FY2015 · GM
Cytochrome C Oxidase in Malignant Gliomas
$303,988Corinne E. Griguer · University Of Alabama At Birmingham · R01 · FY2015 · CA
In vivo detection of involvement of endogenous BM progenitor cells in glioma
$303,988Ali Syed Arbab · Henry Ford Health System · R01 · FY2012 · CA
Cytochrome C Oxidase in Malignant Gliomas
$303,988Corinne E. Griguer · University Of Alabama At Birmingham · R01 · FY2012 · CA
Cytochrome C Oxidase in Malignant Gliomas
$303,988Corinne E. Griguer · University Of Alabama At Birmingham · R01 · FY2016 · CA
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.
$303,988Sandra Ann Rempel · Henry Ford Health System · R01 · FY2011 · CA
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
$303,988Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2015 · CA
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
$303,988Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2016 · CA
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.
$303,988Sandra Ann Rempel · Henry Ford Health System · R01 · FY2012 · CA
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
$303,988Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2012 · CA
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
$303,948Denise C Connolly · Research Inst Of Fox Chase Can Ctr · R01 · FY2013 · CA
Nanostructured Matrices for Cancer Cell Biology
$303,940Milan Mrksich · Northwestern University At Chicago · U54 · FY2010 · CA
Oxygen as a master immunologic switch
$303,925Christopher A Pennell · University Of Minnesota · R01 · FY2014 · CA
Oligonucleotide Synthesis & NanoConstructs Core
$303,908Teri Wang Odom · Northwestern University At Chicago · U54 · FY2016 · CA
Multi-omic CSF Assay for the Diagnosis of Brain Cancers
$303,845Brian Coe · Belay Diagnostics, Llc · R42 · FY2024 · NS
Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas
$303,786Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Interrogation and interpretation of protein kinase signaling dynamics at single-cell resolution
$303,734Min Xue · University Of California Riverside · R35 · FY2021 · GM
Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction
$303,659Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2025 · CA
Xenograft Model for Studying Amplified EGFR in GBM
$303,657Charles David James · University Of California, San Francisco · R01 · FY2007 · NS